News Focus
News Focus
icon url

oldmystic

12/12/25 4:40 PM

#511767 RE: RedShoulder #511766

I think the statement is weak Red.
With all due respect.
icon url

123tom

12/12/25 4:49 PM

#511772 RE: RedShoulder #511766

… and so the phrase they used to frame the process is… “investigational use of an agent in development “. Would that suggest anticipating new trials developing? And the next step is a fresh reexamination by new rapporteurs.
An agent in development. 🤔
will slow and steady win the race? Slowly introducing, educating and showing the regulators the new paradigm of treatment.
How many more months now will the sellers and short attackers have to bleed the price down and down from here, while we wait.
icon url

Hoskuld

12/12/25 5:32 PM

#511790 RE: RedShoulder #511766

Commitment to the process apparently (at least publicly) unchanged from November guidance.